FDA Approves FibroScan® for Non-invasive Liver Diagnosis

05:06 EDT 16 Apr 2013 | PR Newswire
This article has expired, however you can still download the PDF.
PARIS, April 16, 2013 /PRNewswire/ --  - Echosens™ is pleased to announce that FibroScan® device received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on April 5th, 2013 and is now ready to market its pioneering te...

Other Sources for this Article


More From BioPortfolio on "FDA Approves FibroScan® for Non-invasive Liver Diagnosis"

Search BioPortfolio:

Relevant Topic

Latest News Clinical Trials Research Drugs Reports Corporate
Diseases affecting the gastrointestinal tract, which includes the organs from mouth to anus, along the alimentary canal, are the focus of this specialty. Physicians practicing in this field of medicine are called gastroenterologists.  Gastroenterolo...